• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
AF and Venous Thromboembolism - Pathophysiology, Risk Assessment and CHADS-VASc score.心房颤动与静脉血栓栓塞——病理生理学、风险评估及CHADS-VASc评分
J Atr Fibrillation. 2012 Oct 6;5(3):649. doi: 10.4022/jafib.649. eCollection 2012 Oct-Nov.
2
Additive effect of the metabolic syndrome score to the conventional CHADS₂ score for the thromboembolic risk stratification of patients with atrial fibrillation.代谢综合征评分对传统CHADS₂评分在房颤患者血栓栓塞风险分层中的附加作用。
Heart Rhythm. 2014 Mar;11(3):352-7. doi: 10.1016/j.hrthm.2013.11.014. Epub 2013 Nov 16.
3
Comparison between CHADS2 and CHA2 DS2 -VASc score in a stroke cohort with atrial fibrillation.房颤脑卒中患者中 CHADS2 评分与 CHA2DS2-VASc 评分的比较。
Eur J Neurol. 2013 Apr;20(4):623-8. doi: 10.1111/j.1468-1331.2012.03807.x. Epub 2012 Jul 27.
4
CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention.CHADS2、CHA2DS2-VASc和HAS-BLED作为接受经皮冠状动脉介入治疗的房颤患者预后的预测指标。
Thromb Res. 2014 Apr;133(4):560-6. doi: 10.1016/j.thromres.2014.01.007. Epub 2014 Jan 11.
5
Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.抗栓治疗对伴有慢性肾脏病的心房颤动患者的净临床获益：一项全国性观察性队列研究。
J Am Coll Cardiol. 2014 Dec 16;64(23):2471-82. doi: 10.1016/j.jacc.2014.09.051.
6
Correlation of CHADS2 and CHA2DS2-VASc scores with transesophageal echocardiography risk factors for thromboembolism in a multiethnic United States population with nonvalvular atrial fibrillation.多民族美国人群中非瓣膜性心房颤动患者 CHADS2 和 CHA2DS2-VASc 评分与经食管超声心动图血栓栓塞危险因素的相关性。
J Am Soc Echocardiogr. 2013 Feb;26(2):175-84. doi: 10.1016/j.echo.2012.11.002. Epub 2012 Dec 17.
7
Stroke mechanism in patients with non-valvular atrial fibrillation according to the CHADS2 and CHA2 DS2 -VASc scores.根据 CHADS2 和 CHA2 DS2 -VASc 评分的非瓣膜性心房颤动患者的卒中机制。
Eur J Neurol. 2012 Mar;19(3):473-9. doi: 10.1111/j.1468-1331.2011.03547.x. Epub 2011 Oct 4.
8
Roles of the CHADS2 and CHA2DS2-VASc scores in post-myocardial infarction patients: Risk of new occurrence of atrial fibrillation and ischemic stroke.CHADS2和CHA2DS2-VASc评分在心肌梗死后患者中的作用：新发房颤和缺血性卒中的风险
Cardiol J. 2014;21(5):474-83. doi: 10.5603/CJ.a2014.0034. Epub 2014 May 20.
9
Predictive role of CHADS2 and CHA2DS2-VASc scores on stroke and thromboembolism in patients without atrial fibrillation: a meta-analysis.CHADS2和CHA2DS2-VASc评分对非房颤患者中风和血栓栓塞的预测作用：一项荟萃分析
Ann Med. 2016 Aug;48(5):367-75. doi: 10.1080/07853890.2016.1179390. Epub 2016 May 6.
10
The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.CHA2DS2-VASc 评分在 CHADS2 评分为 0-1 的房颤患者中对卒中风险分层的价值：一项全国性队列研究。
Thromb Haemost. 2012 Jun;107(6):1172-9. doi: 10.1160/TH12-03-0175. Epub 2012 Apr 3.

引用本文的文献

1
The Safety of Apixaban Compared to Warfarin in Hospitalized Patients with Acute Kidney Injury.阿哌沙班与华法林相比在急性肾损伤住院患者中的安全性
J Clin Med. 2025 Jul 2;14(13):4685. doi: 10.3390/jcm14134685.
2
Effect of Danhong injection on pharmacokinetics and pharmacodynamics of rivaroxaban in rats.丹红注射液对大鼠利伐沙班药代动力学和药效学的影响。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr;398(4):3617-3629. doi: 10.1007/s00210-024-03453-5. Epub 2024 Oct 1.
3
Modulating activity of PVN neurons prevents atrial fibrillation induced circulation dysfunction by electroacupuncture at BL15.调节室旁核神经元的活动可预防电针BL15诱导的心房颤动引起的循环功能障碍。
Chin Med. 2023 Oct 17;18(1):135. doi: 10.1186/s13020-023-00841-6.
4
Temporal trends in anticoagulation use and clinical outcomes among medicare beneficiaries with non-valvular atrial fibrillation.非瓣膜性心房颤动的医疗保险受益人群中抗凝治疗的使用及临床结局的时间趋势。
J Thromb Thrombolysis. 2024 Jan;57(1):1-10. doi: 10.1007/s11239-023-02838-2. Epub 2023 Aug 2.
5
Allostatic load in opioid use disorder: a scoping review protocol.阿片类物质使用障碍中的应激负荷：范围综述方案。
BMJ Open. 2023 Mar 17;13(3):e060522. doi: 10.1136/bmjopen-2021-060522.
6
Performance of digital early warning score (NEWS2) in a cardiac specialist setting: retrospective cohort study.数字早期预警评分（NEWS2）在心脏专科环境中的表现：回顾性队列研究。
BMJ Open. 2023 Mar 13;13(3):e066131. doi: 10.1136/bmjopen-2022-066131.
7
Clinical Characteristics and Predictors of Long-Term Prognosis of Acute Peripheral Arterial Ischemia Patients Treated Surgically.手术治疗的急性周围动脉缺血患者的临床特征和长期预后预测因素。
Int J Environ Res Public Health. 2023 Feb 22;20(5):3877. doi: 10.3390/ijerph20053877.
8
Contemporary prevalence estimates of undiagnosed and diagnosed atrial fibrillation in the United States.美国未诊断和诊断心房颤动的当代流行率估计。
Clin Cardiol. 2023 May;46(5):484-493. doi: 10.1002/clc.23983. Epub 2023 Mar 1.
9
New onset atrial fibrillation during orthotopic liver transplantation induced by iced saline injection for transpulmonary thermodilution: a case report.经肺温度稀释法注射冰盐水导致原位肝移植中发生新发心房颤动：一例报告。
J Int Med Res. 2022 Oct;50(10):3000605221132711. doi: 10.1177/03000605221132711.
10
A Case of Failed Dual Antiplatelet Therapy With Oral Anticoagulant in the Prevention of Acute Ischemic Stroke.口服抗凝剂联合双重抗血小板治疗预防急性缺血性卒中失败1例
Cureus. 2021 Jun 25;13(6):e15915. doi: 10.7759/cureus.15915. eCollection 2021 Jun.

本文引用的文献

1
Pulmonary embolism and deep vein thrombosis.肺栓塞与深静脉血栓形成。
Lancet. 2012 May 12;379(9828):1835-46. doi: 10.1016/S0140-6736(11)61904-1. Epub 2012 Apr 10.
2
Risk factors for stroke and thromboembolism in relation to age among patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.房颤患者中与年龄相关的中风和血栓栓塞风险因素：卢瓦尔河谷房颤项目。
Chest. 2012 Jan;141(1):147-153. doi: 10.1378/chest.11-0862. Epub 2011 Jun 16.
3
Impact of vascular disease in predicting stroke and death in patients with atrial fibrillation: the Danish Diet, Cancer and Health cohort study.血管疾病对预测房颤患者卒中与死亡的影响：丹麦饮食、癌症与健康队列研究。
J Thromb Haemost. 2011 Jul;9(7):1301-7. doi: 10.1111/j.1538-7836.2011.04308.x.
4
Risk factors and incidence of ischemic stroke in Taiwanese with nonvalvular atrial fibrillation-- a nation wide database analysis.台湾地区非瓣膜性心房颤动患者缺血性脑卒中的风险因素和发生率——一项全国性数据库分析。
Atherosclerosis. 2011 Jul;217(1):292-5. doi: 10.1016/j.atherosclerosis.2011.03.033. Epub 2011 Apr 5.
5
Early stroke-related deep venous thrombosis: risk factors and influence on outcome.早期卒中相关的深静脉血栓形成：危险因素及对预后的影响。
J Thromb Thrombolysis. 2011 Jul;32(1):96-102. doi: 10.1007/s11239-010-0548-3.
6
Hypercoagulability and hypofibrinolysis and risk of deep vein thrombosis and splanchnic vein thrombosis: similarities and differences.高凝状态和低纤维蛋白溶解与深静脉血栓形成和内脏静脉血栓形成的风险：相似性和差异性。
Arterioscler Thromb Vasc Biol. 2011 Mar;31(3):485-93. doi: 10.1161/ATVBAHA.110.213371.
7
Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study.验证用于预测心房颤动患者中风和血栓栓塞风险分层方案的有效性：全国队列研究。
BMJ. 2011 Jan 31;342:d124. doi: 10.1136/bmj.d124.
8
A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice.在普通实践中对 79884 例心房颤动患者的中风风险分层方案进行比较。
J Thromb Haemost. 2011 Jan;9(1):39-48. doi: 10.1111/j.1538-7836.2010.04085.x.
9
Age as a risk factor for stroke in atrial fibrillation patients: implications for thromboprophylaxis.年龄是房颤患者中风的一个危险因素：对血栓预防的影响。
J Am Coll Cardiol. 2010 Sep 7;56(11):827-37. doi: 10.1016/j.jacc.2010.05.028.
10
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).心房颤动管理指南：欧洲心脏病学会（ESC）心房颤动管理特别工作组
Eur Heart J. 2010 Oct;31(19):2369-429. doi: 10.1093/eurheartj/ehq278. Epub 2010 Aug 29.

心房颤动与静脉血栓栓塞——病理生理学、风险评估及CHADS-VASc评分

AF and Venous Thromboembolism - Pathophysiology, Risk Assessment and CHADS-VASc score.

作者信息

Shariff Nasir, Aleem Abdul, Singh Mukesh, Z Li Yuan, J Smith Stacey

机构信息

Department of Cardiovascular Medicine, Lehigh Valley Health Network, Pennsylvania, USA.

Sri Siddhartha Medical College, Karnataka, India.

出版信息

J Atr Fibrillation. 2012 Oct 6;5(3):649. doi: 10.4022/jafib.649. eCollection 2012 Oct-Nov.

DOI:10.4022/jafib.649
PMID:28496776
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5153216/
Abstract

Atrial fibrillation (AF) and venous thromboembolism (VTE) are the two most common medical conditions managed with anti-coagulation therapy. Not all the patients with decreased mobility or AF have a similar risk for thromboembolism. The risk factors for venous thromboembolism and thromboembolism associated with AF are described in various studies. Considering that the two conditions have similar pathophysiologic basis of clot formation, one could imply that the risk factors for the occurrence of thrombosis could be similar. The present review focuses on the similarities and differences in the clinical risk factors of VTE and AF related thromboembolism. We will also be discussing the role of CHADS-VASc scoring system in the risk assessment of VTE.

摘要

心房颤动（AF）和静脉血栓栓塞症（VTE）是接受抗凝治疗的两种最常见的病症。并非所有行动不便或患有房颤的患者发生血栓栓塞的风险都相似。关于静脉血栓栓塞症以及与房颤相关的血栓栓塞症的风险因素，已有多项研究进行了描述。鉴于这两种病症在血栓形成方面具有相似的病理生理基础，有人可能会认为血栓形成的风险因素可能相似。本综述重点关注VTE和房颤相关血栓栓塞症临床风险因素的异同。我们还将讨论CHADS-VASc评分系统在VTE风险评估中的作用。